| group |
dose |
GGT(U/L) |
LDH(U/L) |
NAG(U/L) |
|||
| AP/BL |
AP+BL |
AP/BL |
AP+BL |
AP/BL |
AP+BL |
||
| blank control |
- |
0.62 ± 0.46 |
0.60 ± 0.24 |
0.00 ± 0.00 |
−4.39 ± 0.75 |
0.84 ± 0.09 |
9.97 ± 0.93 |
| medium control |
- |
1.55 ± 0.29# |
1.11 ± 0.10# |
4.47 ± 0.47## |
9.56 ± 1.00### |
1.02 ± 0.06 |
10.45 ± 0.27 |
| DMSO control |
- |
1.70 ± 0.89 |
1.09 ± 0.13# |
6.12 ± 3.95 |
13.62 ± 3.41## |
1.09 ± 0.09 |
11.00 ± 1.26 |
| TTE |
10 μg・ml−1 |
3.91 ± 0.50 |
0.65 ± 0.14 |
22.71 ± 25.62 |
7.67 ± 2.45 |
1.07 ± 0.07 |
10.61 ± 1.18 |
|
|
40 μg・ml−1 |
3.60 ± 2.10 |
1.11 ± 0.18 |
9.66 ± 3.47 |
9.38 ± 3.05 |
1.13 ± 0.05 |
11.01 ± 1.62 |
|
|
160 μg・ml−1 |
5.65 ± 3.98 |
1.90 ± 0.10* |
18.70 ± 4.25* |
27.33 ± 5.99* |
1.19 ± 0.09 |
10.82 ± 1.33 |
|
|
640 μg・ml−1 |
3.76 ± 0.22 |
2.89 ± 0.38** |
4.95 ± 0.80 |
62.20 ± 3.43*** |
1.24 ± 0.21 |
11.05 ± 1.12 |
| blank control |
- |
0.61 ± 0.62 |
0.16 ± 0.10 |
0.00 ± 0.00 |
−0.70 ± 0.78 |
1.02 ± 0.02 |
10.13 ± 0.32 |
| medium control |
- |
1.84 ± 0.25 |
1.16 ± 0.19## |
3.00 ± 0.48## |
24.63 ± 3.01## |
1.03 ± 0.05 |
12.31 ± 1.17 |
| DMSO control |
- |
1.94 ± 0.55 |
1.22 ± 0.12### |
4.16 ± 1.63# |
31.23 ± 7.33# |
0.95 ± 0.08 |
12.81 ± 1.90 |
| triptolide |
4 ng・ml−1 |
1.80 ± 0.29 |
1.11 ± 0.15 |
1.92 ± 0.44 |
33.07 ± 5.94 |
0.93 ± 0.11 |
12.87 ± 1.70 |
|
|
16 ng・ml−1 |
1.66 ± 0.86 |
1.20 ± 0.15 |
2.24 ± 0.37 |
36.66 ± 1.23 |
0.96 ± 0.11 |
12.96 ± 2.01 |
|
|
64 ng・ml−1 |
1.40 ± 0.31 |
1.30 ± 0.12 |
3.17 ± 0.34 |
44.30 ± 6.90 |
1.12 ± 0.11 |
13.26 ± 1.87 |
|
|
256 ng・ml−1 |
4.22 ± 0.62** |
2.48 ± 0.35* |
8.67 ± 1.53* |
126.58 ± 14.71** |
1.50 ± 0.07* |
17.14 ± 0.42* |